Titel

Merkliste
1 Ergebnisse

Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer..:

Bins, Sander ; Huitema, ADR ; Laven, P...
Bins , S , Huitema , ADR , Laven , P , El Bouazzaoui , S , Yu , HX , van Erp , N , van Herpen , C , Hamberg , P , Gelderblom , H , Steeghs , N , Sleijfer , S , van Schaik , R , Mathijssen , R & Koolen , S 2019 , ' Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients ' , Clinical Pharmacokinetics , vol. 58 , no. 5 , pp. 651-658 . https://doi.org/10.1007/s40262-018-0719-5. , 2019

Link: https://pure.eur.nl/en/publications/338c60cc-0b63-4b08..

RT Journal
T1 <Title>Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients</Title>

UL https://suche.suub.uni-bremen.de/peid=base-fturottercrispub:oai:pure.eur.nl:publications_338c60cc-0b63-4b08-a27a-28e6aad33a51&Exemplar=1&LAN=DE
				
A1 Bins, Sander
A1 Huitema, ADR
A1 Laven, P
A1 El Bouazzaoui, Samira
A1 Yu, HX
A1 van Erp, N
A1 van Herpen, C
A1 Hamberg, P
A1 Gelderblom, H
A1 Steeghs, N
A1 Sleijfer, Stefan
A1 van Schaik, Ron
A1 Mathijssen, Ron
A1 Koolen, Stijn
YR 2019
K1 /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
K1 SDG 3 - Good Health and Well-being
JF Bins , S , Huitema , ADR , Laven , P , El Bouazzaoui , S , Yu , HX , van Erp , N , van Herpen , C , Hamberg , P , Gelderblom , H , Steeghs , N , Sleijfer , S , van Schaik , R , Mathijssen , R & Koolen , S 2019 , ' Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients ' , Clinical Pharmacokinetics , vol. 58 , no. 5 , pp. 651-658 . https://doi.org/10.1007/s40262-018-0719-5
LK http://dx.doi.org/https://pure.eur.nl/en/publications/338c60cc-0b63-4b08-a27a-28e6aad33a51
DO https://pure.eur.nl/en/publications/338c60cc-0b63-4b08-a27a-28e6aad33a51
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)